Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
National Marine Biodiversity Institute Of Korea has 1 pending office action currently under review. This action is assigned to 1 distinct examiner, JAUHARI, SACHI. The data shows 0 distinct art units associated with this portfolio, indicating a very limited scope of current prosecution activity. JAUHARI, SACHI is the busiest examiner with 1 pending office action. With only a single pending matter and one distinct examiner, the prosecution is highly centralized, allowing for a focused approach to this specific application.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| §112 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JAUHARI, SACHI | 1 | 60.0% | +80.0% |
| WANG, CHANG YU | 1 | 33.4% | +53.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18786152 | ANTIVIRAL COMPOSITION COMPRISING OCTOMININ | JAUHARI, SACHI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18786152 | ANTIVIRAL COMPOSITION COMPRISING OCTOMININ | JAUHARI, SACHI | — |
| 18010139 | COMPOSITION FOR PREVENTING OR TREATING NEUROLOGICAL DISEASES RELATED TO COPPER METABOLISM, COMPRISING MULTI-COPPER OXIDASE PEPTIDE | WANG, CHANG YU | — |
| Art Unit | Apps |
|---|---|
| 1654 | 1 |
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18786152 | ANTIVIRAL COMPOSITION COMPRISING OCTOMININ | JAUHARI, SACHI | 1654 | §101§102§103§112 | Non-Final OA | — | Pending | Jul 26, 2024 |
| 18010139 | COMPOSITION FOR PREVENTING OR TREATING NEUROLOGICAL DISEASES RELATED TO COPPER METABOLISM, COMPRISING MULTI-COPPER OXIDASE PEPTIDE | WANG, CHANG YU | 1675 | §112 | Final Rejection | — | Pending | Dec 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNational Marine Biodiversity Institute Of Korea has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Sachi Jauhari has the most, with 1 of National Marine Biodiversity Institute Of Korea's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.